Gad-el-Mawla N
Cancer Chemother Pharmacol. 1986;18 Suppl 2:S55-6. doi: 10.1007/BF00647453.
Ifosfamide was studied in advanced pancreatic tumor at the National Cancer Institute, Cairo. Over five years, 25 patients received a daily dose of 1.8 g ifosfamide for five days, courses reported every 21 days. Complete remission was achieved in 1 patient and partial remission in 14 patients, an overall result of 60%, average duration of response being 12+ months. Mesna was used for uroprotection.
开罗国家癌症研究所对晚期胰腺肿瘤患者使用异环磷酰胺进行了研究。在五年时间里，25名患者连续五天每日接受1.8克异环磷酰胺治疗，每21天为一个疗程。1例患者实现完全缓解，14例患者部分缓解，总体缓解率为60%，平均缓解持续时间为12个月以上。使用美司钠进行尿路保护。
